← Back to Search

Provider supervision/ feedback for Peripheral Arterial Disease (ROMEPAD Trial)

N/A

Waitlist Available

Led By Subhash Banerjee, MD, MBA

Research Sponsored by Dallas VA Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

ROMEPAD Trial Summary

This trial will compare two groups of people with peripheral arterial disease - those who do home exercise with a digital monitoring system and provider supervision, and those who just use the monitoring system.

Eligible Conditions

Peripheral Arterial Disease

ROMEPAD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in 6 minute walk test distance between groups

Secondary outcome measures

Change in VascuQOL-6 (VQ6) quality of life survey

Change in Walking Impairment Questionnaire score

ROMEPAD Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Provider SupervisedExperimental Treatment1 Intervention

Digital monitoring system with provider supervision

Group II: Self SupervisedActive Control1 Intervention

Digital monitoring system without provider supervision

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dallas VA Medical CenterLead Sponsor

34 Previous Clinical Trials

4,779 Total Patients Enrolled

1 Trials studying Peripheral Arterial Disease

12 Patients Enrolled for Peripheral Arterial Disease

Subhash Banerjee, MD, MBAPrincipal InvestigatorDallas VA Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals is this research engaging?

"Affirmative. Clinicaltrials.gov indicates the on-going recruitment of participants for this medical study initiated November 21st 2021, with its most recent edit occuring January 13th 2022. The trial is targeting 56 patients from a single site."

Answered by AI

Are there any vacancies in this clinical experiment available to people seeking treatment?

"This clinical trial is still recruiting patients, as noted on its listing page of the clinicialtrials.gov website. The post was first published on November 21st 2021 and had been last updated three months later, on January 13th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Remote Monitoring of Home Exercise in Peripheral Arterial Disease

Subhash Banerjee 2021. "Remote Monitoring of Home Exercise in Peripheral Arterial Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05209724.

All > Pad